Ancora Advisors’s ELITE PHARMACEUTICAL ELI Stock Holding History

Ancora Advisors’s Portfolio ELI Stock Details ELI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,182	Closed	-$3.32K	–	2557
2025 Q3	$3.32K	Hold	5,182	–	–	﹤0.01%	1579
2025 Q2	$3.79K	Hold	5,182	–	–	﹤0.01%	1533
2025 Q1	$2.25K	Buy	+5,182	New	+$2.25K	﹤0.01%	1513

Other funds holding ELI

KFA

Kelleher Financial Advisors New York $705M AUM 16.14% 1-Year Est. Return

Ancora Advisors's ELI Position: Q4 2025 in Review

Ancora Advisors sold out of ELITE PHARMACEUTICAL (ELI) in Q4 2025, closing a stake of 5,182 shares — an estimated $3.32K sold.

Ancora Advisors first reported a position in ELI in Q1 2025 and held it in 3 quarters. The position peaked at $3.79K in Q2 2025. 1 fund tracked by Wall St. Rank holds ELI as of Q4 2025.

Ancora Advisors reported no remaining ELITE PHARMACEUTICAL position as of Q4 2025 after selling out during the quarter.
Ancora Advisors sold 5,182 ELITE PHARMACEUTICAL shares in Q4 2025, an estimated $3.32K.
Ancora Advisors first reported a position in ELITE PHARMACEUTICAL in Q1 2025 and held it in 3 quarters.
Ancora Advisors's ELITE PHARMACEUTICAL position peaked at $3.79K in Q2 2025.
1 fund tracked by Wall St. Rank held ELITE PHARMACEUTICAL as of Q4 2025.

Based on Ancora Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.